Volume 21 - Issue 6 - June, 2009
Insights
Commentary
06/09/2009
Victor Ochoa, MD and Yerem Yeghiazarians, MD
Victor Ochoa, MD and Yerem Yeghiazari...
The debate continues in the cardiology community over indications of percutaneous closure of patent foramen ovale (PFO) with or without an associated atrial septal aneurysm (ASA). Observational studies with control cohorts have shown an...
The debate continues in the cardiology community over indications of percutaneous closure of patent foramen ovale (PFO) with or without an associated atrial septal aneurysm (ASA). Observational studies with control cohorts have shown an...
The debate continues in the...
06/09/2009
Journal of Invasive Cardiology
Commentary
06/09/2009
Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis and is associated with a high risk of cardiovascular morbidity and mortality. Despite the magnitude of the problem, PAD is often poorly recognized in clinical...
Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis and is associated with a high risk of cardiovascular morbidity and mortality. Despite the magnitude of the problem, PAD is often poorly recognized in clinical...
Peripheral arterial disease...
06/09/2009
Journal of Invasive Cardiology
Commentary
06/09/2009
Allen Jeremias, MD, MSc and Luis Gruberg, MD
Allen Jeremias, MD, MSc and Luis Grub...
The routine use of more potent antiplatelet and antithrombotic therapies led to substantial improvements in outcomes after percutaneous coronary intervention (PCI) and has contributed to the interventionist’s ability to treat more complex...
The routine use of more potent antiplatelet and antithrombotic therapies led to substantial improvements in outcomes after percutaneous coronary intervention (PCI) and has contributed to the interventionist’s ability to treat more complex...
The routine use of more potent...
06/09/2009
Journal of Invasive Cardiology
Feature
Original Contribution
06/09/2009
Carmine Musto, MD, Alberta Cifarelli, MD, Claudia Pandolfi, MD, Francesco De Felice, MD,
Rosario Fiorilli, MD, Giorgia Caferri, MD, Roberto Violini, MDd
Carmine Musto, MD, Alberta Cifarelli,...
ABSTRACT: Objective. We sought to evaluate the short- and long-term outcomes of Amplatzer Multi-Fenestrated Septal Occluder Cribriform (AMF) device use in the percutaneous closure of patent foramen ovale (PFO) associated with atrial septal...
ABSTRACT: Objective. We sought to evaluate the short- and long-term outcomes of Amplatzer Multi-Fenestrated Septal Occluder Cribriform (AMF) device use in the percutaneous closure of patent foramen ovale (PFO) associated with atrial septal...
ABSTRACT: Objective. We sought...
06/09/2009
Journal of Invasive Cardiology
Original Contribution
06/09/2009
Pornthep Lertsapcharoen, MD, Apichai Khongphatthanayothin, MD, Vidhavas La-orkhun, MD,
Kanyalak Vithessonthi, MD, *Suphot Srimahachota, MD
Pornthep Lertsapcharoen, MD, Apichai ...
ABSTRACT: Background. An occluding device for closure of patent ductus arteriosus (PDA) was developed from meshed nitinol wires coated with platinum for prevention of nickel release after implantation. Objectives. Our purpose was to assess...
ABSTRACT: Background. An occluding device for closure of patent ductus arteriosus (PDA) was developed from meshed nitinol wires coated with platinum for prevention of nickel release after implantation. Objectives. Our purpose was to assess...
ABSTRACT: Background. An...
06/09/2009
Journal of Invasive Cardiology
Original Contribution
06/09/2009
*Joseph M. Garasic, MD, §Linda Marin, RN, £R. David Anderson, MD, MS
*Joseph M. Garasic, MD, §Linda Marin...
ABSTRACT: Background. The Mynx™ vascular closure device (VCD) (AccessClosure, Inc., Mountain View, California) is used for extravascular closure of the common femoral artery (CFA) after diagnostic or interventional endovascular procedures....
ABSTRACT: Background. The Mynx™ vascular closure device (VCD) (AccessClosure, Inc., Mountain View, California) is used for extravascular closure of the common femoral artery (CFA) after diagnostic or interventional endovascular procedures....
ABSTRACT: Background. The Mynx™...
06/09/2009
Journal of Invasive Cardiology
Original Contribution
06/09/2009
*Nahel Farraj, DO, §A. Srivastava, MD, *,§,£Ashish Pershad, MD
*Nahel Farraj, DO, §A. Srivastava, M...
ABSTRACT: Objective. The treatment of long superficial femoral artery (SFA) chronic total occlusions (CTOs) remains controversial. There are several percutaneous treatment options available for the recanalization of these lesions....
ABSTRACT: Objective. The treatment of long superficial femoral artery (SFA) chronic total occlusions (CTOs) remains controversial. There are several percutaneous treatment options available for the recanalization of these lesions....
ABSTRACT: Objective. The...
06/09/2009
Journal of Invasive Cardiology
Original Contribution
06/09/2009
ABSTRACT: Background. Gender differences that exist in patients with acute coronary disease (ACD) are unexplained. We sought to determine if these differences could be related to differences in the pathologic substrate found in the coronary...
ABSTRACT: Background. Gender differences that exist in patients with acute coronary disease (ACD) are unexplained. We sought to determine if these differences could be related to differences in the pathologic substrate found in the coronary...
ABSTRACT: Background. Gender...
06/09/2009
Journal of Invasive Cardiology
Original Contribution
06/09/2009
Nicolas W. Shammas, MD, MS, Gail Shammas, RN, Darren Bryan, BS, Jason Rauba, BS,
Eric Dippel, MD, Michael Jerin, PhD
Nicolas W. Shammas, MD, MS, Gail Sham...
ABSTRACT: Background. Predictors of target lesion revascularization (TLR) have not been well defined in patients undergoing peripheral percutaneous interventions (PPI). In this study we analyze predictors of TLR in a consecutive cohort of...
ABSTRACT: Background. Predictors of target lesion revascularization (TLR) have not been well defined in patients undergoing peripheral percutaneous interventions (PPI). In this study we analyze predictors of TLR in a consecutive cohort of...
ABSTRACT: Background. Predictors...
06/09/2009
Journal of Invasive Cardiology
Original Contribution
06/09/2009
Dmitriy N. Feldman, MD, S. Chiu Wong, MD, Geoffrey Bergman, MD, Robert M. Minutello, MD
Dmitriy N. Feldman, MD, S. Chiu Wong...
Frequency and Outcomes of Provisional Glycoprotein IIb/IIIa Blockade in Patients Receiving Bivalirudin during Percutaneous Coronary Intervention
ABSTRACT: Objectives. This study sought to evaluate the frequency and efficacy of combination...
Frequency and Outcomes of Provisional Glycoprotein IIb/IIIa Blockade in Patients Receiving Bivalirudin during Percutaneous Coronary Intervention
ABSTRACT: Objectives. This study sought to evaluate the frequency and efficacy of combination...
Frequency and Outcomes of...
06/09/2009
Journal of Invasive Cardiology
